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Fatty acid composition of adipose tissue changes with weight 
loss. Palmitoleic acid as a possible marker of endogenous 
lipogenesis or its functions as a lipokine are under debate. 
Objective was to assess the predictive role of adipose 
triglycerides fatty acids in weight maintenance in participants of 
the DIOGENES dietary intervention study. After an 8-week low 
calorie diet (LCD) subjects with > 8 % weight loss were 
randomized to 5 ad libitum weight maintenance diets for 
6 months: low protein (P)/low glycemic index (GI) (LP/LGI), low 
P/high GI (LP/HGI), high P/low GI (HP/LGI), high P/high GI 
(HP/HGI), and a control diet. Fatty acid composition in adipose 
tissue triglycerides was determined by gas chromatography in 
195 subjects before the LCD (baseline), after LCD and weight 
maintenance. Weight change after the maintenance phase was 
positively correlated with baseline adipose palmitoleic (16:1n-7), 
myristoleic (14:1n-5) and trans-palmitoleic acid (16:1n-7t). 
Negative correlation was found with baseline oleic acid (18:1n-9). 
Lower baseline monounsaturated fatty acids (14:1n-5, 16:1n-7 
and trans 16:1n-7) in adipose tissue triglycerides predict better 
weight maintenance. Lower oleic acid predicts lower weight 
decrease. These findings suggest a specific role of 
monounsaturated fatty acids in weight management and as 
weight change predictors.  
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The fatty acid composition of adipose tissue 
reflects dietary fatty acid intake and also endogenous 
processing of fat, i.e. lipolysis and endogenous 
lipogenesis. Associations between obesity, diabetes 
mellitus and insulin sensitivity with specific patterns of 
fatty acid composition of serum phospholipids 
(Pelikánová et al. 2001, Zák et al. 2007, Huang et al. 
2010), muscle membrane phospholipids (Borkman et al. 
1993, Baur et al. 1999), skeletal muscle triglycerides 
(Manco et al. 2000), erythrocyte phospholipids (Ntali et 
al. 2011) and adipose tissue triglycerides (Iggman et al. 
2010) have been reported. Endothelial dysfunction in 
type 2 diabetics has also been related to fatty acid 
composition; saturated fatty acids were related to 
endothelial dysfunction, while polyunsaturated fatty acids 
(PUFA) showed protective effects (Perassolo et al. 2008). 
A higher proportion of saturated fatty acids in serum 
phospholipids seemed to be related to insulin resistance 
while higher levels of polyunsaturated fatty acids are 
related to increased insulin sensitivity (Pelikánová et al. 
2001). Recent studies brought evidence for varying 
relationships of individual saturated fatty acids to insulin 
sensitivity and obesity (Sampath and Ntambi 2005, 
Iggman et al. 2010). 
Previously, we found that palmitoleic acid 
(16:1n-7) in serum cholesteryl esters and adipose tissue 
triglycerides correlated with multiple measures of 
adiposity and adipose tissue distribution (Kunešová et al. 
2002a). Palmitoleic acid is the product of desaturation of 
palmitic acid (16:0) by stearoyl CoA desaturase 1 (delta-9 
desaturase, SCD1). In monozygotic twins, before and 
after weight loss followed by one year weight 
maintenance, highly significant intrapair resemblance of 
palmitoleic acid percentage in all serum lipid classes 
(cholesteryl esters, phospholipids and triglycerides) and 
in adipose tissue triglycerides were found independently 
of dietary fat intake. This result suggests palmitoleic acid 
as a metabolic indicator under genetic control reflecting 
endogenous lipogenesis (Kunešová et al. 2002a,b). In 
experimental studies palmitoleic acid was suggested as a 
possible ”lipokine” that allows adipose tissue to 
communicate with distant organs (Cao et al. 2008). 
However, this lipokine function was not confirmed by 
other authors, who showed that adipose tissue palmitoleic 
acid corresponds to endogenous lipogenesis (Hertzel et 
al. 2006, Gong et al. 2011). On the contrary, circulating 
palmitoleic acid in serum free fatty acids strongly and 
independently predicted insulin sensitivity in subjects at 
increased risk of type 2 diabetes (Stefan et al. 2010). 
Interestingly, trans-palmitoleic acid in serum 
phospholipids, which represents fatty acid mostly 
received from exogenous sources, was associated with 
slightly lower adiposity and independently associated 
with significantly lower insulin resistance (Mozaffarian et 
al. 2010).  
To investigate the role of protein and glycemic 
index of carbohydrates in the weight maintenance after 
weight loss, the multicentre Pan European DIOGENES 
dietary intervention study was performed. Overweight 
and obese subjects started an eight weeks weight loss 
period using a low calorie formula diet (LCD 3.2 MJ per 
day). Only subjects with at least 8 % loss of initial weight 
were eligible to start the weight maintenance phase 
lasting 6 months. For this period the subjects were 
randomized to five groups with different dietary protein 
content and glycemic index. Energy intake during weight 
maintenance period was ad libitum. The DIOGENES 
dietary intervention is part of the European integrated 
project on Diet, Obesity and genes (DIOGENES, 
www.diogenes-eu.org) (Saris and Harper 2005). The 
study was performed in 8 European centers and the 
results of the 6 months weight maintenance period were 
published recently (Larsen et al. 2010).  
The aim of this part of the DIOGENES project 
was to assess the fatty acid composition of adipose tissue 
triglycerides at baseline, after 8 weeks of LCD and after 
6 months of weight maintenance and to evaluate their 
change during this period. The second aim was to 
evaluate the baseline levels of adipose tissue fatty acids 
as possible predictors of weight change, change in body 
fat distribution and body composition during the weight 
loss and maintenance period.  
 
Material and Methods 
 
Subjects and study design 
Subjects examined in this study were 
participants of the DIOGENES project in which adipose 
tissue biopsies were performed before the start of the 
study, after the LCD period and after the 6-month weight 
maintenance period. Fatty acid composition of AT 
triglycerides was analyzed and necessary clinical data 
were available. This subgroup of the total DIOGENES 
cohort was selected from 8 centers depending on the 
availability of the fat biopsies for fatty acid analysis. 
Baseline characteristics of the subjects and effect of the 
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low calorie diet and weight maintenance period are given 
in Table 1.  
The study protocol, methods, procedures and 
data processing have been described previously (Larsen 
et al. 2009, 2010, www.diogenes-eu.org) as well as the 
dietary intervention (Moore et al. 2009). Briefly, the 
subjects were screened and a baseline examination was 
performed (clinical investigation day 1, CID 1). The 
subjects then started the weight loss phase following a 
LCD 3.2 MJ/day (Modifast, Nutrition et Santé, France) 
supplemented with up to 400 g/d of vegetables. At the 
end of the LCD period, they were examined again 
(CID2). Subjects who reached a weight loss ≥8 % of their 
initial body weight were randomized to one of the 
following diets: low protein, low glycemic index 
(LPLGI), low protein high glycemic index (LPHGI), high 
protein low glycemic index (HPLGI), high protein high 
glycemic index (HPHGI) and control diet (C) given the 
relevant national dietary guidelines. They were instructed 
to follow the ad libitum randomized diet for six months. 
Following the 6 months weight maintenance period the 
subjects were examined again (CID 3). Fasting blood 
samples were drawn at each of the 3 CIDs for the analysis 
of blood metabolites. Samples of subcutaneous adipose 
tissue were obtained from the periumbilical area by 
needle aspiration under local anesthesia following an 
overnight fast at each of the time points. All procedures 
were standardized between study centers across Europe, 
and biopsy samples were stored at –80 °C until analysis. 
The lipid fraction was extracted from the fat cake during 
RNA extraction by using the RNeasy total RNA Mini kit 
(Qiagen) (Márquez-Quiñones et al. 2010). The values of 
the anthropometric and laboratory parameters are marked 
1, 2 and 3 according to CID in which they were obtained. 
 
 
Table 1. Characteristics of subjects before the treatment and after LCD and weight maintenance phase. 
 
Variable Before LCD Weight maintenance 
Age 42.05±5.61   
Weight (kg)  96.67±15.53 85.67±13.79* 86.99±14.47* 
Height (m) 1.69±0.09   
BMI  33.57±4.41 29.84±4.06* 30.22±4.25*+ 
Waist (cm) 105.46±12.06 95.70±11.79* 96.55±11.47* 
Hip (cm) 115.71±10.17 108.16±9.68* 108.88±9.88* 
SAD (cm) 24.61±3.73 21.44±3.33* 21.70±6.45* 
SBP (mm Hg) 123.27±13.74 116.16±13.44* 120.63±13.59*+ 
DBP (mm Hg) 75.63±10.39 71.78±10.12* 73.22±10.78*+ 
FM (kg) 38.19±10.64 30.12±10.50* 30.50±10.52* 
FM (%) 39.44±8.25 34.87±10.08* 34.85±9.44* 
 
n=195, mean ± S.D., * p<0.05 in comparison with basal level, + p<0.05 in comparison with LCD level. 
 
 
Fatty acid composition  
Analysis of the fatty acid composition of the 
lipid fraction consisting of adipose tissue triglycerides 
was performed by gas chromatography. Total lipid was 
transmethylated to fatty acid methyl esters (FAME) with 
1M sodium methoxide in dry methanol under nitrogen 
atmosphere in darkness (60 min at laboratory 
temperature). The reaction mixture was neutralized with 
1M acetic acid, FAME were extracted twice into hexane 
and passed through a column (5 x 20 mm) of anhydrous 
sodium sulphate. The combined extracts were dried under 
nitrogen, dissolved in an appropriate volume of isooctane 
and stored at –20 °C until analyzed. Gas chromatography 
was performed with a Trace GC (Thermo Finnigan, USA) 
gas chromatograph equipped with a capillary 
split/splitless injector and flame-ionization detector 
(FID), combined with AS 2000 autosampler (Thermo 
Finnigan). Analyses of FAME were performed on fused-
silica capillary columns coated with chemically bonded 
stationary phases Select FAME (100 m x 0.32 mm I.D.) 
(Varian, the Netherlands). The oven temperature was 
programmed from 80 °C to 260 °C at a rate 2 °C/min, 
then isothermal 25 min. The injector and detector 
temperatures were 250 and 270 °C, respectively. 
Hydrogen carrier gas was maintained at a head pressure 
of 70 kPa and total flow 25 ml/min. Integration software 
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Clarity for Windows® (Data Apex® Ltd., Praha) was 
used for data acquisition and handling. Ratios  
16:1n-7/16:0 and 18:1n-9/18:0 were used as measures of 
SCD activity because they reflect stearoyl CoA gene 
expression (SCD, delta-9 desaturase, Sjögren et al. 2007). 
 
Statistical methods 
The data were evaluated by repeated measures 
ANOVA with Bonferroni correction. To eliminate skewed 
data distribution and heteroscedasticity, the original data 
was transformed to a Gaussian distribution by a Box-Cox 
transformation before further processing using the  
statistical software Statgraphics Centurion, version XVI 
from Statpoint Inc. (Herndon, Virginia, USA). 
The relationships between change of 
anthropometric characteristics (matrix Y) and their initial 
Table 2. Percentage of fatty acids in adipose triglycerides during the weight management. 
  
Variable Before LCD Weight maintenance 
12:0 0.29±0.01 0.25±0.009* 0.30±0.01+ 
14:0 2.57±0.04 2.36±0.04* 2.44±0.05*+ 
14:1n5 0.26±0.007 0.23±0.006* 0.24±0.007*+ 
16:0 23.26±0.15 22.73±0.15* 22.58±0.15* 
16:1n-7c 4.57±0.09 4.23±0.09* 4.25±0.09* 
16:1n-7t 0.032±0.001 0.028±0.001* 0.027±0.001*+ 
16:1n-9 0.66±0.007 0.70±0.006* 0.67±0.007*+ 
18:0 3.79±0.06 3.85±0.05 3.98±0.06* 
18:1n-7c 1.91±0.02 1.89±0.03 1.86±0.02 
18:1n-9c 46.14±0.22 47.15±0.22* 46.82±0.23*+ 
18:1n-9sum t 1.03±0.03 1.04±0.02 1.03±0.02 
18:2n-6cc 12.45±0.15 12.44±0.16 12.66±0.15*+ 
18:2n-6tt 0.013±0.0007 0.011±0.0005* 0.011±0.0005* 
18:2n-6tc 0.10±0.005 0.092±0.005* 0.097±0.006* 
18:2n-6ct 0.047±0.002 0.038±0.002* 0.036±0.002* 
18:3n-6alc 0.05±0.002 0.05±0.001 0.05±0.002+ 
18:3n-3alc 0.47±0.02 0.41±0.02* 0.42±0.02+ 
20:0 0.35±0.02 0.31±0.02 0.34±0.02 
20:1n-9c 0.63±0.008 0.69±0.009* 0.70±0.008* 
20:2n-6cc 0.19±0.003 0.21±0.004* 0.20±0.003* 
20:3n-9alc 0.024±0.0009 0.026±0.0009 0.026±0.001 
20:3n-6alc 0.24±0.006 0.27±0.006* 0.26±0.006*+ 
20:4n-6alc 0.41±0.007 0.44±0.008* 0.44±0.008* 
20:5n-3alc 0.06±0.002 0.05±0.002 0.06±0.003 
22:4n-6alc 0.14±0.004 0.16±0.004* 0.16±0.003* 
22:5n-6alc 0.035±0.0002 0.036±0.001 0.029±0.001*+ 
22:5n-3alc 0.15±0.004 0.17±0.004* 0.17±0.004* 
22:6n-3alc 0.11±0.003 0.11±0.004 0.13±0.004*+ 
SFA 30.12±0.22 29.39±0.21* 29.51±0.22* 
MFA 54.18±0.22 54.91±0.23* 54.55±0.23+ 
TFA 1.23±0.03 1.21±0.02 1.20±0.03 
PUFAn-6 13.51±0.15 13.61±0.02 13.8±0.16*+ 
PUFAn-3 0.93±0.02 0.86±0.02* 0.91±0.02+ 
16:1n-7/16:0 0.20±0.004 0.19±0.004 0.19±0.003 
18:1n-9c/18:0 12.76±0.23 12.82±0.24 12.28±0.22 
 
# mean ± S.E., * p<0.05 in comparison with basal level, + p<0.05 in comparison with LCD level. 
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values and initial values of fatty acids and further 
laboratory data (matrix X) were simultaneously evaluated 
using multivariate regression with reduction of 
dimensionality, known as bidirectional orthogonal 
projections to latent structures (O2PLS). The data 
transformed by Box-Cox transformations underwent 
processing by O2PLS method (Trygg and Wold 2002, 
Trygg et al. 2007, Hill et al. 2010). In contrast to 
ordinary multivariate regression or multiple regression, 
O2PLS is effective in coping with the problem of severe 
multicollinearity within the X and within the Y (see 
Table 3). The aforementioned model enabled us to find 
the variables with high predictive value for description of 
relationships between X and Y and to find a structure of 
these relationships.  
We have tested the relevance of individual 
variables for the model using a criterion Variable 
Importance (VIP). Only the variables that showed 
significant relevance for the first and/or the second 
predictive component were included in the model. 
Similarly, the relevant number of predictive components 
was tested using a criterion Prediction Error Sum of 
Squares (PRESS). 
The statistical software SIMCA-P+ Version 
12.0.0.0 from UmetricsAB (Umeå, Sweden) was used for 
data analysis. The software enabled us to find the number 
of the relevant components utilizing the prediction error 
sum of squares and also allowed the detection of 
multivariate non-homogeneities and testing the 
multivariate normal distribution and homoscedasticity 
(homogeneity of variance). 
Relationships between two variables were 
evaluated by Spearman’s correlations. 
Due to significant heterogeneity in weight loss 
between the eight centers – in the Bulgarian group during 
the weight maintenance period significant higher weight 
loss was found in comparison with the other seven 
centers (p<0.001) – we excluded this center from analysis 
in this study. 
 
Ethics 
The study was approved by the local ethics 
committees in the respective countries. The protocol was 
in accordance with the Declaration of Helsinki (2009), all 
study participants signed an informed consent document 





Changes in percentage of individual fatty acids 
in adipose tissue triglycerides are shown in Table 2. In 
comparison with baseline values, decreases in saturated 
(myristic 14:0 and palmitic 16:0), and monounsaturated 
fatty acids (myrimyristoleic 14:1n-5 and palmitoleic acid 
16:1n-7) were found after LCD and weight maintenance 
period and in trans-linoleic acids (18:2 n-6tt,ct and tc) 
after weight maintenance. Significant increases were 
Table 3. Relationships between weight change (weight3 - weight1), (explained variable) and baseline fatty acid composition and 
anthropometrical traits (explanatory variables) evaluated using multivariate regression with reduction of dimensionality (model of 
Orthogonal Projections to Latent Structures, OPLS). 
 
Component of weight loss 
Explained variability = 13 % (10.9 %) 
 
 Variable 
Parametera 95 % CIb 99 % CI 
Parameter/ 
95 % CIb 
Rc 
X Weight1 -0.514 0.093 0.147 -5.54 -0.816** 
X BMI1 -0.501 0.068 0.107 -7.41 -0.795** 
X Waist1 -0.525 0.027 0.043 -19.37 -0.833** 
X FA141n51 0.278 0.069 0.109 4.05 0.442** 
X FA161n7t1 0.264 0.131 0.207 2.01 0.418** 
X FA161n71 0.202 0.103 0.163 1.96 0.321** 
X FA181n9c1 -0.241 0.114 0.181 -2.11 -0.383** 
Y Weight3 - weight1 1.000 0.330 0.522 3.03 0.361** 
 
a…component loadings for the predictive components expressed as regression coefficients; b…confidence interval; c…component 
loadings for the predictive components expressed as correlation coefficients of individual variables with the predictive components. 
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found in oleic acid (18:1n-9) and stearic (18:0) acid after 
weight maintenance, in oleic acid also after LCD. 
Increases were shown in n-6 PUFA´s – linoleic  
(18:2n-6cc), dihomo-gamma-linoleic (20:3n-6), 
arachidonic acid (20:4n-6) and docosatetrenoic acid 
(22:4n-6), and in n-3 PUFA´s eicosapentenoic (EPA, 
22:5n-3) after LCD and weight maintenance and in 
docosahexenoic (DHA,22:6n- 3) after weight 
maintenance only.  
When evaluating percentages of adipose tissue 
fatty acids at baseline (CID1) as predictors of weight 
change after the weight management (CID3-CID1) we 
found that only myristoleic (14:1n-5), palmitoleic  
(16:1n-7) and trans-palmitoleic (16:1n-7 t) acids were 
significantly positively correlated with weight loss, i.e. 
the lower the initial percentage the greater was the weight 
loss. Percentage of oleic acid (18:1n-9) correlated 
negatively with weight loss as well as previously shown 
initial weight and BMI and waist (Handjieva-Darlenska et 
al. 2010) (Table 3, Fig. 1). The variability of the weight 
loss (dependent variable) explained by independent 
variables (initial fatty acids and anthropometrical traits) 
was 13.0 % (10.9 % after cross-validation).  
Spearman rank correlations show significant 
positive association of weight and waist changes after 
weight maintenance with basal sum of saturated fatty 
acids, negative correlation with basal sum of 
monounsaturated fatty acids and SCD activity, expressed 
as ratio 18:1n-9/18:0, the correlation with 16:1n-7/16:0 
was not significant. Trans fatty acids correlated positively 
with weight change only (Table 4). 
The effect of protein quantity in the diet and of 
glycemic index of the diet will be evaluated elsewhere. 
 
 
Table 4. Spearman rank correlations between basal percentage 
of fatty acids in adipose triglycerides and change in weight and 
waist after weight maintenance period. 
 
Fatty acid Weight 3 – weight 2 Waist 3 – waist 2 
Basal values r P r P 
SFA 0.22 0.003 0.28 0.001 
MFA -0.22 0.002 -0.29 0.001 
TFA 0.21 0.003 0.09 NS 
16:1n-7/16:0 -0.001 NS -0.04 NS 
18:1n-9c/18:0 -0.16 0.02 -0.16 0.02 
 






In the DIOGENES group of subjects we found 
significant positive correlations between total weight loss 
with percentage of myristoleic (14:1n-5), palmitoleic 
(16:1n-7) and trans-palmitoleic acid (16:1n-7t) in adipose 
tissue triglycerides at baseline. This outcome in 
agreement with previous findings suggests that 
palmitoleic acid levels in adipose tissue reflect 
endogenous lipogenesis (Kunešová et al. 2002a, Hertzel 
 
Fig. 1. Relationships between change in weight (matrix Y) and
basal anthropometry and adipose triglyceride fatty acid
composition (matrix X). 1 initial values, 3-1 difference between
weight maintenance and initial value. 
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et al. 2006, Gong et al. 2011). Also myristoleic acid 
(product of desaturation of myristic acid in humans), a 
minor fatty acid in adipose tissue, seems to be an 
indicator of endogenous lipogenesis (Lands 1995). This 
observation is in agreement with a study in 1926 subjects 
in which a positive association between adipose tissue 
palmitoleic acid concentrations and adipose tissue 
desaturation indices with obesity was shown (Gong et al. 
2011). In elderly men, a negative correlation of insulin 
sensitivity with dietary and adipose tissue palmitic and 
palmitoleic acid and some PUFA´s (20:3n-6, 20:4n-6, 
22:4n-6, 22:5n-3 and 22:6 n-3) was shown. In this group, 
insulin sensitivity positively correlated with lauric (12:0), 
myristic (14:0), margaric (17:0) and stearic (18:0) acids 
and essential fatty acids linoleic acid (18:2n-6) and alpha 
linolenic acid (18:3n-3). Most associations were 
diminished or disappeared in lean individuals, indicating 
a role of obesity (Iggman et al. 2010). A high proportion 
of palmitoleic acid in serum cholesteryl esters 
independently predicted high plasma glucose 
concentrations after 5 year follow-up in Amerindian 
women (Lindgärde et al. 2006). 
The lipogenic capacity of human adipose tissue 
is lower than in rats (Letexier et al. 2003) and de novo 
lipogenesis is highly regulated, for review see (Strable 
and Ntambi 2010). In mice with modified FABP 
expression a relation between palmitoleate and de novo 
lipogenesis and SCD activity has been shown. In adipose 
tissue of adipose-FABP null mice increased de novo 
lipogenesis was associated with enhanced levels of 
palmitic acid and palmitoleic acid and increased fat mass 
(Hertzel et al. 2006). In mice with FABP (aP2 and mal1) 
mutations characterized by resistance to diet-induced 
obesity and metabolic syndrome significantly enhanced 
insulin receptor signaling, enhanced muscle AMP-
activated kinase (AMP-K) activity, and reduced liver 
SCD activity were found (Maeda et al. 2005). These 
studies show close relationship of palmitate and 
palmitoleate levels with endogenous lipogenesis in mice 
adipose tissue and in liver.  
As shown in recent reviews (Flowers and 
Ntambi 2008, Paton and Ntambi 2008), scd1-deficient 
mice have reduced lipid synthesis and enhanced lipid 
oxidation, thermogenesis and insulin sensitivity in 
various tissues including liver, muscle and adipose tissue. 
SCD 1 is required for protection against dietary 
unsaturated fat deficiency, leptin deficiency-induced 
diabetes, and palmitate-induced lipotoxic insults in 
muscle and pancreatic beta-cells. In obesity, starvation 
and exercise increased muscle SCD1.  
In humans, an association of delta-9 desaturase 
activity with adiposity and plasma lipid profile was 
suggested in a group of healthy adolescent women; this 
supports the assumption that delta-9 activity 
independently reflects higher body mass index and higher 
circulatory triglyceride levels (Zhou et al. 2009). We did 
not find a decrease in SCD1 activity calculated as ratios 
16:1n-7/16:0 and 18:1n-9/18:0 in adipose tissue. This was 
in contrast to a study including a lifestyle intervention 
that found a significant decrease in total and saturated fat 
intake, a decrease in BMI and HOMA insulin resistance 
associated with a decrease in delta-9 desaturase 
(Corpeleijn et al. 2006).  
The relationship between fatty acids reflecting 
endogenous lipogenesis and weight (a marker of total 
adipose tissue) was not related to waist circumference 
(a marker of abdominal fat). This could be related to the 
recently found greater enrichment of palmitoleic acid 
(16:1n-7) associated with higher expression of SCD1 and 
with higher content of SCD1-derived fatty acids in 
gluteofemoral adipose tissue (Pinnick et al. 2012). 
In our study, we found that basal trans-
palmitoleic acid (trans 16:1n-7) was a negative predictor 
of weight loss. This is in contrast to a study showing that 
trans-palmitoleic acid correlates with slightly lower 
adiposity (Mozaffarian et al. 2010). The different result 
could be due to a weak association between dietary 
triglyceride fatty acids, which are predominantly 
saturated, and composition of fatty acids in adipose tissue 
triglycerides (Hodson et al. 2008).  
At the end of the study, we found a significant 
decrease in proportion of the most saturated and 
monounsaturated fatty acids with exception of stearic 
acid (18:0) and oleic acid. Concurrently, we found a 
negative correlation of baseline oleic acid (18:1n-9) with 
total weight loss (the higher baseline oleic acid the higher 
weight loss). Oleic acid was shown to control the 
expression of SCD1 at the transcriptional level leading to 
a decrease in SCD1 mRNA content in human aortic 
smooth muscle cells (Minville-Walz et al. 2012). Oleic 
acid may exert a similar effect in adipose tissue. Stearic 
acid was shown to generate a lower lipemic response in 
comparison with palmitic and myristic acid, and also is a 
poor substrate for TG synthesis (Sampath and Ntambi 
2005). Stearic acid exerts neutral effect also on 
cholesterol metabolism in comparison with saturated fatty 
acids with 12-16 carbons. These results are in agreement 
with a positive relationship of stearic acid to insulin 
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sensitivity and negative to BMI (Roberts et al. 2009, 
Iggman et al. 2010). A lower decrease of stearic acid may 
also reflect a higher decrease in SCD activity. This 
precedes induction of other lipogenic genes and 
transcription factors as sterol regulatory element binding 
protein 1c (SREBP 1c), a key regulator of lipogenic gene 
transcription, carbohydrate response element binding 
protein (ChREBP) (Clark et al. 2002, Biddinger et al. 
2005, Strable and Ntambi 2010) and peroxisome 
proliferator-activated receptor-gamma coactivator-1beta 
(PGC-1beta, Sampath et al. 2007). Insulin effect is 
mediated through SREBP 1c. Leptin (Hodson et al. 
2008), glucagon (Lefevre et al. 1999) and AT II receptor 
blocker (Yokozawa et al. 2009) decrease SCD1 mRNA 
activity. The relationship of stearic acid content with 
insulin sensitivity (positive) and BMI (negative) could be 
mediated by adipocyte size, smaller adipocytes are more 
insulin sensitive. Roberts et al. (2009) have shown a 
strong positive relationship of adipose TG myristic and 
stearic acid with adipocyte size and insulin sensitivity 
(HOMA model) in humans. Lipogenic gene expression 
was shown to be inversely correlated with adipocyte cell 
size. Different regulation was proposed for adipose and 
hepatic de novo lipogenesis (Roberts et al. 2009). This is 
supported by a study showing up-regulation of SCD1 and 
enhancement of SCD activity in the liver of mice treated 
by rosiglitazone possibly in association with insulin 
sensitizing effect of thiazolidinediones (Kuda et al. 
2009). 
The consistent increase was found in this study 
in the percentage of n-6 PUFA and to a lesser extent 
increases in long chain n-3 PUFA [(eicosapentenoic acid 
(20:5n-3), docosapentenoic (22:5n-3) and 
docosahaxenoic acid (22:6n-3)] which most likely 
reflects changes in dietary fat composition during the 
weight maintenance phase (Hlavaty et al. 2008).  
Adipose tissue distribution was shown to be 
related to fatty acid composition. Specifically, central 
obesity was positively associated with n-6 
polyunsaturated fatty acids and inversely associated with 
monounsaturated fatty acids and n-3 polyunsaturated 
fatty acids in adipose tissue (Phinney et al. 1994, 
Garaulet et al. 2001). We found a negative correlation of 
monounsaturated fatty acids and surprisingly also of 
SCD1 activity expressed as 18:1n-9/18:0, questioning 
usage of this ratio as reflection of SCD activity due to 
supposed higher role of exogenous sources of C18 acids, 
and a positive correlation of saturated fatty acids with 
change in weight and waist circumference. 
In conclusion, higher baseline proportion of 
palmitoleic, myristoleic and trans-palmitoleic acids in 
adipose triglycerides predict less successful weight 
maintenance. Conversely, oleic acid percentage 
negatively predicts weight change. During the long term 
weight maintenance diet a favorable change in fatty acid 
composition including a decrease in most saturated and 
monounsaturated (14:1n-5, 16:1n-7, 16:1n-7t) fatty acids 
was found concurrently with an increase in n-6 and to a 
lesser extent also in n-3 polyunsaturated fatty acids.  
 
Conflict of Interest  
There is no conflict of interest. 
 
Acknowledgements 
This work was funded by grant IGA NS 9830-4 of 
Internal Grant Agency Ministry of Health and by EC 




BAUR LA, CONNOR J, PAN DA, STORLIEN H: Relationship between maternal risk of insulin resistance and the 
child´s muscle membrane fatty acid composition. Diabetes 48: 112-113, 1999. 
BIDDINGER SB, ALMIND K, MIYAZAKI M, KOKKOTOU E, NTAMBI JM, KAHN CR: Effects of diet and genetic 
background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development 
of the metabolic syndrome. Diabetes 54: 1314-1323, 2005.  
BORKMAN M, STORLIEN LH, PAN DA, JENKINS AB, CHISHOLM DJ, CAMPBELL LV: The relation between 
insulin sensitivity and the fatty acid composition on skeletal muscle phospholipids. N Engl J Med 328: 238-
244, 1993. 
CAO H, GERHOLD K, MAYERS JR, WIEST MM, WATKINS SM, HOTAMISLIGIL GS: Identification of a 
lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134: 933-944, 2008. 
2012  Fatty Acids in Adipose Triglycerides After Weight Management   605  
   
CLARKE SD, GASPERIKOVA D, NELSON C, LAPILLONNE A, HEIRD WC: Fatty acid regulation of gene 
expression: a genomic explanation for the benefits of the mediterranean diet. Ann N Y Acad Sci 967: 283-298, 
2002. 
CORPELEIJN E, FESKENS EJ, JANSEN EH, MENSINK M, SARIS WH, DE BRUIN TW, BLAAK EE: 
Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in 
serum fatty acid profile and desaturase activities: the SLIM study. Diabetologia 49: 2392-2401, 2006. 
DECLARATION OF HELSINKI: Ethical principles for medical research involving human subjects. J Indian Med 
Assoc 107: 403-405, 2009. 
FLOWERS MT, NTAMBI JM: Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism. Curr Opin 
Lipidol 19: 248-256, 2008. 
GARAULET M, PÉREZ-LLAMAS F, PÉREZ-AYALA M, MARTÍNEZ P, DE MEDINA FS, TEBAR FJ, ZAMORA 
S: Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population 
from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central 
obesity. Am J Clin Nutr 74: 585-591, 2001.  
GONG J, CAMPOS H, MCGARVEY S, WU Z, GOLDBERG R, BAYLIN A: Adipose tissue palmitoleic acid and 
obesity in humans: does it behave as a lipokine? Am J Clin Nutr 93: 186-191, 2011.  
HANDJIEVA-DARLENSKA T, HANDJIEV S, LARSEN TM, VAN BAAK MA, JEBB S, PAPADAKI A, PFEIFFER 
AF, MARTINEZ JA, KUNESOVA M, HOLST C, SARIS WH, ASTRUP A: Initial weight loss on an 800-kcal 
diet as a predictor of weight loss success after 8 weeks: the Diogenes study. Eur J Clin Nutr 64: 994-999, 2010.  
HERTZEL AV, SMITH LA, BERG AH, CLINE GW, SHULMAN GI, SCHERER PE, BERNLOHR DA: Lipid 
metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice. Am J Physiol 
Endocrinol Metab 290: E814-E823, 2006.  
HILL M, PAŘÍZEK A, CIBULA D, KANCHEVA R, JIRÁSEK JE, JIRKOVSKÁ M, VELÍKOVÁ M, KUBÁTOVÁ J, 
KLÍMKOVÁ M, PAŠKOVÁ A, ŽIŽKA Z, KANCHEVA L, KAZIHNITKOVÁ H, ZAMRAZILOVÁ L, 
STÁRKA L: Steroid metabolome in plasma from the umbilical artery, umbilical vein, maternal cubital vein 
and in amniotic fluid in normal and preterm labor. J Steroid Biochem Mol Biol 121: 594-610, 2010. 
HLAVATÝ P, KUNEŠOVÁ M, GOJOVÁ M, TVRZICKÁ E, VECKA M, ROUBAL P, HILL M, HLAVATÁ K, 
KALOUSKOVÁ P, HAINER V, ŽÁK A, DRBOHLAV J: Change in fatty acid composition of serum lipids in 
obese females after short-term weight-reducing regimen with the addition of n-3 long chain polyunsaturated 
fatty acids in comparison to controls. Physiol Res 57 (Suppl 1): S57-S65, 2008.  
HODSON L, SKEAFF CM, FIELDING BA: Fatty acid composition of adipose tissue and blood in humans and its use 
as a biomarker of dietary intake. Prog Lipid Res 47: 348-380, 2008. 
HUANG T, WAHLQVIST ML, XU T, XU A, ZHANG A, LI D: Increased plasma n-3 polyunsaturated fatty acid is 
associated with improved insulin sensitivity in type 2 diabetes in China. Mol Nutr Food Res 54 (Suppl 1): 
S112-S119, 2010. 
IGGMAN D, ARNLÖV J, VESSBY B, CEDERHOLM T, SJÖGREN P, RISÉRUS U: Adipose tissue fatty acids and 
insulin sensitivity in elderly men. Diabetologia 53: 850-857, 2010. 
KUDA O, STANKOVA B, TVRZICKA E, HENSLER M, JELENIK T, ROSSMEISL M, FLACHS P, KOPECKY J: 
Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat 
diet. J Physiol Pharmacol 60: 135-140, 2009. 
KUNEŠOVÁ M, HAINER V, TVRZICKA E, PHINNEY SD, ŠTICH V, PAŘÍZKOVÁ J, ŽÁK A, STUNKARD AJ: 
Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese 
female identical twins. Lipids 37: 27-32, 2002a. 
KUNEŠOVÁ M, PHINNEY S, HAINER V, TVRZICKÁ E, ŠTICH V, PAŘÍZKOVÁ J, ŽÁK A, STUNKARD A: The 
responses of serum and adipose Fatty acids to a one-year weight reduction regimen in female obese 
monozygotic twins. Ann N Y Acad Sci 967: 311-323, 2002b. 
LANDS WE: Long-term fat intake and biomarkers. Am J Clin Nutr 61 (Suppl 3): 721S-725S, 1995. 
606   Kunešová et al.  Vol. 61 
 
 
LARSEN TM, DALSKOV S, VAN BAAK M, JEBB S, KAFATOS A, PFEIFFER A, MARTINEZ JA, HANDJIEVA-
DARLENSKA T, KUNESOVA M, HOLST C, SARIS WH, ASTRUP A: The Diet, Obesity and Genes 
(Diogenes) Dietary Study in eight European countries – a comprehensive design for long-term intervention. 
Obes Rev 11: 76-91, 2009. 
LARSEN TM, DALSKOV SM, VAN BAAK M, JEBB SA, PAPADAKI A, PFEIFFER AF, MARTINEZ JA, 
HANDJIEVA-DARLENSKA T, KUNESOVA M, PIHLSGARD M, STENDER S, HOLST C, SARIS 
WH, ASTRUP A: Diets with high or low protein content and glycaemic index for weight-loss maintenance. 
N Engl J Med 363: 2102-2113, 2010. 
LEFEVRE P, DIOT C, LEGRAND P, DOUAIRE M: Hormonal regulation of stearoyl coenzyme-A desaturase 1 
activity and gene expression in primary cultures of chicken hepatocytes. Arch Biochem Biophys 368: 329-337, 
1999. 
LETEXIER D, PINTEUR C, LARGE V, FRÉRING V, BEYLOT M: Comparison of the expression and activity of the 
lipogenic pathway in human and rat adipose tissue. J Lipid Res 44: 2127-2134, 2003.  
LINDGÄRDE F, VESSBY B, AHRÉN B: Serum cholesteryl fatty acid composition and plasma glucose concentrations 
in Amerindian women. Am J Clin Nutr 84: 1009-1013, 2006.  
MAEDA K, CAO H, KONO K, GORGUN CZ, FURUHASHI M, UYSAL KT, CAO Q, ATSUMI G, MALONE H, 
KRISHNAN B, MINOKOSHI Y, KAHN BB, PARKER RA, HOTAMISLIGIL GS: Adipocyte/macrophage 
fatty acid binding proteins control integrated metabolit responses in obesity and diabetes. Cell Metab 1: 107-
119, 2005. 
MANCO M, MINGRONE G, GRECO AV, CAPRISTO E, GNIULI D, DE GAETANO A, GASBARRINI G: Insulin 
resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism 
49: 220-224, 2000. 
MÁRQUEZ-QUIÑONES A, MUTCH DM, DEBARD C, WANG P, COMBES M, ROUSSEL B, HOLST C, 
MARTINEZ JA, HANDJIEVA-DARLENSKA T, KALOUSKOVA P, JEBB S, BABALIS D, PFEIFFER AF, 
LARSEN TM, ASTRUP A, SARIS WH, MARIMAN E, CLÉMENT K, VIDAL H, LANGIN D, VIGUERIE 
N, DiOGenes Project: Adipose tissue transcriptome reflects variations between subjects with continued weight 
loss and subjects regaining weight 6 mo after caloric restriction independent of energy intake. Am J Clin Nutr 
92: 975-984, 2010.  
MINVILLE-WALZ M, GRESTI J, PICHON L, BELLENGER S, BELLENGER J, NARCE M, RIALLAND M: 
Distinct regulation of stearoyl-CoA desaturase 1 gene expression by cis and trans C18:1 fatty acids in human 
aortic smooth muscle cells. Genes Nutr 7: 209-216, 2012. 
MOORE CS, LINDROOS AK, KREUTZER M, LARSEN TM, ASTRUP A, VAN BAAK MA, HANDJIEVA-
DARLENSKA T, HLAVATY P, KAFATOS A, KOHL A, MARTINEZ JA, MONSHEIMER S, JEBB SA: 
Dietary strategy to manipulate ad libitum macronutrient intake, and glycaemic index, across eight European 
countries in the Diogenes Study. Obes Rev 11: 67-75, 2009. 
MOZAFFARIAN D, CAO H, KING IB, LEMAITRE RN, SONG X, SISCOVICK DS, HOTAMISLIGIL GS: Trans-
palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med 
153: 790-799, 2010. 
NTALI G, KOUTSARI C, KARAKIKE K, MAKRAS P, SKOPOULI F, MC MILAN M, SLATER C, HIGGINS S, 
ZAMPELAS A, MALKOVA D: Erythrocyte fatty acid composition and insulin sensitivity in daughters of 
Type 2 diabetic patients and women with no family history of diabetes. J Endocrinol Invest 33: 306-312, 2010.  
PATON CM, NTAMBI JM: Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol 
Endocrinol Metab 297: E28-E37, 2009.  
PELIKÁNOVÁ T, KAZDOVÁ L, CHVOJKOVÁ S, BASE J: Serum phospholipid fatty acid composition and insulin 
action in type 2 diabetic patients. Metabolism 50: 1472-1478, 2001. 
PERASSOLO MS, ALMEIDA JC, STEEMBURGO T, DALL'ALBA V, DE MELLO VD, ZELMANOVITZ T, DE 
AZEVEDO MJ, GROSS JL: Endothelial dysfunction and serum fatty acid composition in patients with type 2 
diabetes mellitus. Metabolism 57: 1167-1172, 2008. 
PHINNEY SD, STERN JS, BURKE KE, TANG AB, MILLER G, HOLMAN RT: Human subcutaneous adipose tissue 
shows site-specific differences in fatty acid composition. Am J Clin Nutr 60: 725-729, 1994. 
2012  Fatty Acids in Adipose Triglycerides After Weight Management   607  
   
PINNICK KE, NEVILLE MJ, FIELDING BA, FRAYN KN, KARPE F, HODSON L: Gluteofemoral adipose tissue 
plays a major role in production of the lipokine palmitoleate in humans. Diabetes 61: 1399-1403, 2012. 
ROBERTS R, HODSON L, DENNIS AL, NEVILLE MJ, HUMPHREYS SM, HARNDEN KE, MICKLEM KJ, 
FRAYN KN: Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin 
sensitivity in humans. Diabetologia 52: 882-890, 2009. 
SAMPATH H, NTAMBI JM: The fate and intermediary metabolism of stearic acid. Lipids 40: 1187-1191, 2005. 
SAMPATH H, MIYAZAKI M, DOBRZYN A, NTAMBI JM: Stearoyl-CoA desaturase-1 mediates the pro-lipogenic 
effects of dietary saturated fat. J Biol Chem 282: 2483-2493, 2007. 
SARIS WH, HARPER A: DIOGenes: A multidisciplinary offensive focused on the obesity epidemic. Obes Rev 6: 175-
176, 2005. 
SJÖGREN P, SIERRA-JOHNSON J, GERTOW K, ROSELL M, VESSBY B, DE FAIRE U, HAMSTEN A, 
HELLENIUS ML, FISHER RM: Fatty acid desaturases in human adipose tissue: relationships between gene 
expression, desaturation indexes and insulin resistance. Diabetologia 51: 328-335, 2008. 
STEFAN N, KANTARTZIS K, CELEBI N, STAIGER H, MACHANN J, SCHICK F, CEGAN A, ELCNEROVA M, 
SCHLEICHER E, FRITSCHE A, HÄRING HU: Circulating palmitoleate strongly and independently predicts 
insulin sensitivity in humans. Diabetes Care 33: 405-407, 2010. 
STRABLE MS, NTAMBI JM: Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem 
Mol Biol 45: 199-214, 2010. 
TRYGG J, WOLD S: Orthogonal projections to latent structure. J Chemometrics 16: 119-128, 2002.  
TRYGG J, HOLMES E, LUNDSTEDT TJ: Chemometrics in metabonomics. J Proteome Res 6: 469-479, 2007. 
YOKOZAWA J, SASAKI T, OHWADA K, SASAKI Y, ITO JI, SAITO T, KAWATA S: Down-regulation of hepatic 
stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat: possible 
role in amelioration of insulin resistance and hepatic steatosis. J Gastroenterol 44: 583-591, 2009. 
ZÁK A, TVRZICKÁ E, VECKA M, JÁCHYMOVÁ M, DUFFKOVÁ L, STANKOVÁ B, VÁVROVÁ L, 
KODYDKOVÁ J, ZEMAN M: Severity of metabolic syndrome unfavorably influences oxidative stress and 
fatty acid metabolism in men. Tohoku J Exp Med 212: 359-371, 2007. 
ZHOU YE, EGELAND GM, MELTZER SJ, KUBOW S: The association of desaturase 9 and plasma fatty acid 
composition with insulin resistance-associated factors in female adolescents. Metabolism 58: 158-166, 2009. 
 
 
 
 
